HOME >> MEDICINE >> NEWS
Calcium channel gene may play a role in severity of neurodegenerative brain disease

LOS ANGELES (Embargoed until April 15, 2002; 4:00 p.m., Central) -- Researchers at Cedars-Sinai Medical Center and at the Centro Investigacin Rehabilitacin de Ataxia, in Holguin, Cuba have identified a gene that affects the severity and onset of a rare brain disease. The condition, called spinocerebellar ataxia, is a disease caused by a gene mutation and characterized by a loss of balance and coordination. The finding, reported at the 54th Annual Meeting of the American Academy of Neurology, may lead to new ways to effectively treat the disease.

Our research shows that a certain form of SCA6, a gene that regulates the entry of calcium into the cells, influences the severity of spinocerebellar ataxia, said Stefan-M. Pulst, M.D., who holds the Carmen and Louis Warschaw Chair in Neurology at Cedars-Sinai Medical Center and is senior author of the study.

Spinocerebellar ataxia is caused by a loss of function in the cerebellum, the part of the brain that controls coordination. The disease causes clumsiness and a loss of coordination in the hands, arms, legs, speech and eye movements. Usually SCA2 occurs in adulthood, but it can also occur in childhood or very late in life despite identical gene mutations. In either situation, SCA2 is caused by a gene mutation made up of very long repeats of three chemical bases (C-A-G) in the DNA sequence that tend to get bigger over time. In successive generations, for example, the length of the C-A-G repeat becomes longer and causes the disease to occur at an earlier age. However, only about 60 percent of the variation in age of onset can be explained by the C-A-G repeat length, with the remaining 40 percent having no relationship to the size of the repeat.

To determine why people with identical gene mutations developed the disease at different ages and degrees of severity, the investigators analyzed 331 patients with SCA2 from Holguin, Cuba, where SCA2 is common due to a large Founder effect or wher
'"/>

Contact: Kelli Stauning
kelli.stauning@cshs.org
310-423-3674
Cedars-Sinai Medical Center
15-Apr-2002


Page: 1 2

Related medicine news :

1. Calcium and vitamin D most effective for treatment of Crohns-related bone loss
2. Calcium boost to youths bones could reduce osteoporosis risk
3. Calcium channel blocker reduces adverse cardiovascular events in certain patients
4. Calcium-blocker drug slows artery clogging better than beta blocker
5. Calcium-dependent potassium channels as target to increase drug delivery to brain tumors
6. Calcium intake may be associated with reduced risk of colon cancer
7. This summer, Camp Calcium is where the boys are
8. American Heart Association Comment On New England Journal Of Medicine Report OnCalcium Antagonist Nisoldipine (March 5 issue)
9. Some brain cells change channels to fine-tune the message
10. Major new study finds long-acting calcium channel blockers inferior to other antihypertensive drugs
11. Researchers discover alcohol-sensitive membrane channel

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology:
Cached News: